학술논문
Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial
Document Type
Article
Author
Source
In: Trials . (Trials, December 2022, 23(1))
Subject
Language
English
ISSN
17456215